At a glance
ClinicalIndex Comparison RecordN/ACompleted· 780 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-interventional Study of Six-month Retrospective Reporting of Hemoglobin Levels in Patients With Renal Anaemia Who Are Treated With MIRCERA® (Methoxy-polyethylene-glycol-epoetin Beta)
In Brief
An observational study for Anemia, Kidney Disease, Chronic. Completed, enrolled 780 participants across 17 sites.
Detailed Summary
This retrospective observational study will evaluate the hemoglobin levels in patients with renal anemia over 6 months treatment with Mircera (methoxy polyethylene glycol-epoetin beta).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Kidney Disease, Chronic
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
Primary CompletionFeb 2011
First PostedJun 2011
TodayJul 2026
First PostedJun 23, 2011
Enrollment StartApr 30, 2009
Primary CompletionFeb 28, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.0 years ago